383 related articles for article (PubMed ID: 33833449)
1. High-density lipoproteins, reverse cholesterol transport and atherogenesis.
Pownall HJ; Rosales C; Gillard BK; Gotto AM
Nat Rev Cardiol; 2021 Oct; 18(10):712-723. PubMed ID: 33833449
[TBL] [Abstract][Full Text] [Related]
2. Rethinking reverse cholesterol transport and dysfunctional high-density lipoproteins.
Gillard BK; Rosales C; Xu B; Gotto AM; Pownall HJ
J Clin Lipidol; 2018; 12(4):849-856. PubMed ID: 29731282
[TBL] [Abstract][Full Text] [Related]
3. Revisiting Reverse Cholesterol Transport in the Context of High-Density Lipoprotein Free Cholesterol Bioavailability.
Rosales C; Gillard BK; Xu B; Gotto AM; Pownall HJ
Methodist Debakey Cardiovasc J; 2019; 15(1):47-54. PubMed ID: 31049149
[TBL] [Abstract][Full Text] [Related]
4. New insights into the regulation of HDL metabolism and reverse cholesterol transport.
Lewis GF; Rader DJ
Circ Res; 2005 Jun; 96(12):1221-32. PubMed ID: 15976321
[TBL] [Abstract][Full Text] [Related]
5. HDL Function and Atherosclerosis: Reactive Dicarbonyls as Promising Targets of Therapy.
Linton MF; Yancey PG; Tao H; Davies SS
Circ Res; 2023 May; 132(11):1521-1545. PubMed ID: 37228232
[TBL] [Abstract][Full Text] [Related]
6. Alterations in high-density lipoprotein metabolism and reverse cholesterol transport in insulin resistance and type 2 diabetes mellitus: role of lipolytic enzymes, lecithin:cholesterol acyltransferase and lipid transfer proteins.
Borggreve SE; De Vries R; Dullaart RP
Eur J Clin Invest; 2003 Dec; 33(12):1051-69. PubMed ID: 14636288
[TBL] [Abstract][Full Text] [Related]
7. Liver ABCA1 deletion in LDLrKO mice does not impair macrophage reverse cholesterol transport or exacerbate atherogenesis.
Bi X; Zhu X; Duong M; Boudyguina EY; Wilson MD; Gebre AK; Parks JS
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2288-96. PubMed ID: 23814116
[TBL] [Abstract][Full Text] [Related]
8. [Role of HDL in Cholesterol Efflux and Reverse Cholesterol Transport].
Ayaori M
Rinsho Byori; 2016 Jan; 64(1):57-65. PubMed ID: 27192798
[TBL] [Abstract][Full Text] [Related]
9. The Yin and Yang of High-density Lipoprotein and Atherosclerotic Cardiovascular Disease: Focusing on Functionality and Cholesterol Efflux to Reframe the HDL Hypothesis.
Ganjali S; Watts GF; Banach M; Reiner Ž; Nachtigal P; Sahebkar A
Curr Med Chem; 2021; 28(29):6066-6081. PubMed ID: 33563147
[TBL] [Abstract][Full Text] [Related]
10. Overexpression and deletion of phospholipid transfer protein reduce HDL mass and cholesterol efflux capacity but not macrophage reverse cholesterol transport.
Kuwano T; Bi X; Cipollari E; Yasuda T; Lagor WR; Szapary HJ; Tohyama J; Millar JS; Billheimer JT; Lyssenko NN; Rader DJ
J Lipid Res; 2017 Apr; 58(4):731-741. PubMed ID: 28137768
[TBL] [Abstract][Full Text] [Related]
11. Effects of high-density lipoprotein(2) on cholesterol transport and acyl-coenzyme A:cholesterol acyltransferase activity in P388D1 macrophages.
Li L; Pownall HJ
Biochim Biophys Acta; 2001 Jan; 1530(1):111-22. PubMed ID: 11341963
[TBL] [Abstract][Full Text] [Related]
12. Increased atherosclerosis in mice lacking apolipoprotein A-I attributable to both impaired reverse cholesterol transport and increased inflammation.
Moore RE; Navab M; Millar JS; Zimetti F; Hama S; Rothblat GH; Rader DJ
Circ Res; 2005 Oct; 97(8):763-71. PubMed ID: 16151025
[TBL] [Abstract][Full Text] [Related]
13. JCL roundtable: High-density lipoprotein function and reverse cholesterol transport.
Cuchel M; Rohatgi A; Sacks FM; Guyton JR
J Clin Lipidol; 2018; 12(5):1086-1094. PubMed ID: 30314802
[TBL] [Abstract][Full Text] [Related]
14. High-density lipoprotein: key molecule in cholesterol efflux and the prevention of atherosclerosis.
Meurs I; Van Eck M; Van Berkel TJ
Curr Pharm Des; 2010 May; 16(13):1445-67. PubMed ID: 20199377
[TBL] [Abstract][Full Text] [Related]
15. Lipoproteins and atherosclerosis.
Babiak J; Rudel LL
Baillieres Clin Endocrinol Metab; 1987 Aug; 1(3):515-50. PubMed ID: 3330421
[TBL] [Abstract][Full Text] [Related]
16. Diet modification alters plasma HDL cholesterol concentrations but not the transport of HDL cholesteryl esters to the liver in the hamster.
Woollett LA; Kearney DM; Spady DK
J Lipid Res; 1997 Nov; 38(11):2289-302. PubMed ID: 9392427
[TBL] [Abstract][Full Text] [Related]
17. Reverse cholesterol transport in plasma of patients with different forms of familial HDL deficiency.
von Eckardstein A; Huang Y; Wu S; Funke H; Noseda G; Assmann G
Arterioscler Thromb Vasc Biol; 1995 May; 15(5):691-703. PubMed ID: 7749883
[TBL] [Abstract][Full Text] [Related]
18. Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor.
Bashore AC; Liu M; Key CC; Boudyguina E; Wang X; Carroll CM; Sawyer JK; Mullick AE; Lee RG; Macauley SL; Parks JS
Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1747-1761. PubMed ID: 31167565
[TBL] [Abstract][Full Text] [Related]
19. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins.
Wang N; Lan D; Chen W; Matsuura F; Tall AR
Proc Natl Acad Sci U S A; 2004 Jun; 101(26):9774-9. PubMed ID: 15210959
[TBL] [Abstract][Full Text] [Related]
20. What does procollagen C-endopeptidase enhancer protein 2 have to do with HDL-cholesteryl ester uptake? Or how I learned to stop worrying and love reverse cholesterol transport?
Sorci-Thomas MG; Pollard RD; Thomas MJ
Curr Opin Lipidol; 2015 Oct; 26(5):420-5. PubMed ID: 26218419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
